The 'Pink Pill': The Female Viagra?
Why the first licensed drug to treat low sexual desire in women is proving controversial. Melanie Abbott investigates how 'the pink pill' came to be approved in the USA.
The 'pink pill' flibanserin has been called 'the female Viagra', but critics argue its benefits are few and side effects many.
Melanie Abbott investigates how the failed anti-depressant came to be licensed in the USA, and what the future plans are to bring the drug to Europe.
Presenter: Melanie Abbott
Producer: James Melley
Researcher: Phoebe Keane.
Last on
More episodes
Previous
Late Night Woman's Hour: Lust
Lauren Laverne talks lust with Caitlin Moran and ex-dominatrix Nichi Hodgson.
Diabetes: A Surgical Solution?
Could increasing access to weight loss surgery help the battle against diabetes?
Treating Stroke: The Doctors' Dilemma
Does a leading stroke drug cause more harm than good?
Broadcast
- Thu 1 Oct 2015 20:00大象传媒 Radio 4
Featured in...
The Best of The Report: NHS and Healthcare
Investigating developments within the NHS and wider healthcare system.
Download this programme
Subscribe to this programme or download individual episodes.
The Best of The Report
Listen again to the best investigations from The Report team
Podcast
-
The Report
Original insights into major news stories and topical investigations